Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear ...

Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A ...

A compound derived from rosemary, known as carnosic acid, has been transformed into a potent brain-boosting drug that combats Alzheimer’s by reducing inflammation and stress in the brain — all while ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

The appendix may play a further role in protecting the gastrointestinal system from invading pathogens. This would explain ...

SLC35B1 transports ATP into the ER, and its structure offers potential for targeted therapies in diseases linked to ER stress ...

National Institutes of Health Director Jay Bhattacharya claimed the dean of Stanford Medical School asked him to stop ...

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and ...

The CEO of Connect Biopharma discusses the unique challenges that patients with asthma and COPD face. Pharmaceutical ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Sixteen year old Hanlon Thompson from Ochapowace First Nation in southeastern Saskatchewan has a rare autoimmune condition.